BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2008
View Archived Issues
Genentech presents preclinical, clinical data on GDC-0941
Read More
Exelixis discloses results on its investigational compounds for cancer
Read More
EA-230 lessens kidney damage in porcine peritonitis
Read More
SCIO-469 does not meet primary endpoint in a phase II rheumatoid arthritis study
Read More
Novel agents for treating endocrine-related disorders disclosed in recent patent literature
Read More
Anesiva discontinues Zingo, reports results from phase III trial of Adlea
Read More
Cell Therapeutics reports results from phase III trial of pixantrone in NHL
Read More
Almirall signs agreement with Pfizer to commercialize Astucor in Spain for cardiovascular protection
Read More
Sangamo reports results from diabetic neuropathy trial SB-509-601
Read More
Lorus completes IND-enabling studies for LOR-253
Read More
INNO-406 shows encouraging responses in phase I chronic myeloid leukemia trial
Read More
Phase II IMC-1121B study commences in first-line treatment of NSCLC
Read More
TNFerade receives FDA fast track designation for pancreatic cancer
Read More
Two phase I studies with novel cancer vaccine in two different routes of administration
Read More
Marillion and Bracco sign license agreement for cancer drug 177Lu-AMBA
Read More
Lipocine completes clinical study establishing feasibility of once-daily ziprasidone
Read More
Alba Therapeutics enrolls first European patient in global phase IIb larazotide study
Read More
Raptor reports results from phase IIa study of Convivia in ALDH2 deficiency
Read More
Novartis reports results from AGELESS study of direct renin inhibitor Rasilez
Read More
Acrux adds novel formulations of topical pain relief drugs to product pipeline
Read More
Biovitrum extends ReFacto supply agreement with Wyeth
Read More
Helion receives funding to continue development of MASP-2
Read More
Recent Bayer Schering patent reports novel antiviral agents
Read More
Novel NNRTIs reported by Roche
Read More